{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:32:33Z","timestamp":1787776353008,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301904"],"award-info":[{"award-number":["2021YFC2301904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301900"],"award-info":[{"award-number":["2021YFC2301900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341072"],"award-info":[{"award-number":["82341072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272316"],"award-info":[{"award-number":["82272316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["SQ2024YFE0202254"],"award-info":[{"award-number":["SQ2024YFE0202254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20240304045SF"],"award-info":[{"award-number":["20240304045SF"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145715","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:09:15Z","timestamp":1751454555000},"page":"145715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P4","title":["A novel FITC.Chimeric antigen receptor-T cell targeting HIV-1-infected cells with FITC-conjugated antibodies for enhanced cytotoxicity"],"prefix":"10.1016","volume":"319","author":[{"given":"Zhizhong","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baisong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10425","key":"10.1016\/j.ijbiomac.2025.145715_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","article-title":"HIV epidemiology, prevention, treatment, and implementation strategies for public health","volume":"403","author":"Mody","year":"2024","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.145715_bb0010","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"T. iPrEx Study, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"vol. 363","author":"Grant","year":"2010","journal-title":"N Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145715_bb0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1086\/498163","article-title":"Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women","volume":"192","author":"Johnson","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"9903","key":"10.1016\/j.ijbiomac.2025.145715_bb0020","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0025","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1038\/s41467-019-11893-4","article-title":"Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145715_bb0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/aid.2018.0118","article-title":"Barriers for HIV cure: the latent reservoir","volume":"34","author":"Castro-Gonzalez","year":"2018","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145715_bb0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/COH.0000000000000485","article-title":"Chimeric antigen receptor T-cell approaches to HIV cure","volume":"13","author":"Kuhlmann","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.145715_bb0040","doi-asserted-by":"crossref","first-page":"9712","DOI":"10.1128\/JVI.00852-16","volume":"90","author":"Liu","year":"2016","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41421-024-00658-z","article-title":"Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study","volume":"10","author":"Mao","year":"2024","journal-title":"Cell Discov."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145715_bb0050","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V84.9.2878.2878","article-title":"Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors","volume":"84","author":"Roberts","year":"1994","journal-title":"Blood"},{"issue":"132","key":"10.1016\/j.ijbiomac.2025.145715_bb0055","doi-asserted-by":"crossref","first-page":"132ra53","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145715_bb0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/mthe.2002.0611","article-title":"A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"5","author":"Deeks","year":"2002","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145715_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd4597","article-title":"The pharmacology of second-generation chimeric antigen receptors","volume":"14","author":"Stegen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145715_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003354","article-title":"4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells","volume":"9","author":"Roselli","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0075","doi-asserted-by":"crossref","first-page":"1034707","DOI":"10.3389\/fimmu.2022.1034707","article-title":"Next generations of CAR-T cells - new therapeutic opportunities in hematology?","volume":"13","author":"Tomasik","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0080","doi-asserted-by":"crossref","first-page":"ltab016","DOI":"10.1093\/immadv\/ltab016","article-title":"Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers","volume":"1","author":"Harrison","year":"2021","journal-title":"Immunother. Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40364-020-00237-w","article-title":"PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo","volume":"8","author":"Liao","year":"2020","journal-title":"Biomark. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145715_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virs.2023.01.003","article-title":"Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env(+) cells invivo","volume":"38","author":"Pan","year":"2023","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.684016","article-title":"HIV-1-specific CAR-T cells with cell-intrinsic PD-1 checkpoint blockade enhance anti-HIV efficacy in vivo","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Microbiol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.145715_bb0100","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1128\/JVI.00805-16","article-title":"HIV-1-specific chimeric antigen receptors based on broadly neutralizing antibodies","volume":"90","author":"Ali","year":"2016","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12977-018-0455-9","article-title":"Antibody-mediated prevention and treatment of HIV-1 infection","volume":"15","author":"Gruell","year":"2018","journal-title":"Retrovirology"},{"issue":"7424","key":"10.1016\/j.ijbiomac.2025.145715_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145715_bb0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-Pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.145715_bb0120","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145715_bb0125","first-page":"1003","volume":"384","author":"Corey","year":"2021","journal-title":"H.H.S."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145715_bb0130","article-title":"Advancing aggregation-induced emission-derived biomaterials in viral, tuberculosis, and fungal infectious diseases","volume":"6","author":"Wei Wang","year":"2025","journal-title":"Aggregate"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12943-024-02151-3","article-title":"CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside","volume":"23","author":"Zhu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101412","article-title":"Immunological approaches to HIV cure","volume":"51","author":"Ward","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0145","doi-asserted-by":"crossref","first-page":"1288383","DOI":"10.3389\/fonc.2023.1288383","article-title":"CAR-T treatment for cancer: prospects and challenges","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145715_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2019.05.003","article-title":"The UniCAR system: a modular CAR T cell approach to improve the safety of CAR T cells","volume":"211","author":"Bachmann","year":"2019","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12967-023-04041-6","article-title":"Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility","volume":"21","author":"Celichowski","year":"2023","journal-title":"J. Transl. Med."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145715_bb0165","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1158\/1078-0432.CCR-12-1449","article-title":"Redirecting gene-modified T cells toward various cancer types using tagged antibodies","volume":"18","author":"Tamada","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"748","key":"10.1016\/j.ijbiomac.2025.145715_bb0170","doi-asserted-by":"crossref","first-page":"eadn0223","DOI":"10.1126\/scitranslmed.adn0223","article-title":"Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice","volume":"16","author":"Cottrell","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145715_bb0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.chom.2024.04.008","article-title":"Designing boosting immunogens for HIV-1 vaccine development","volume":"32","author":"Liu","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"6060","key":"10.1016\/j.ijbiomac.2025.145715_bb0180","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1213782","article-title":"Increasing the potency and breadth of an HIV antibody by using structure-based rational design","volume":"334","author":"Diskin","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145715_bb0185","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-Pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145715_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/aid.2015.0258","article-title":"Improvements and limitations of humanized mouse models for HIV research: NIH\/NIAID \u201cmeet the experts\u201d 2015 workshop summary","volume":"32","author":"Akkina","year":"2016","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0195","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jit319","article-title":"Overcoming current limitations in humanized mouse research","volume":"208 Suppl 2(Suppl 2)","author":"Brehm","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0200","article-title":"Humanized mice for the evaluation of novel HIV-1 therapies","volume":"12","author":"Abeynaike","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145715_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0000000000001674","article-title":"An advanced BLT-humanized mouse model for extended HIV-1 cure studies","volume":"32","author":"Lavender","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0210","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2018.00746","article-title":"The use of the humanized mouse model in gene therapy and immunotherapy for HIV and Cancer","volume":"9","author":"Carrillo","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145715_bb0215","first-page":"135","article-title":"Humanized mouse models of HIV infection","volume":"13","author":"Denton","year":"2011","journal-title":"AIDS Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145715_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11081984","article-title":"Current advances in humanized mouse models for studying NK cells and HIV infection","volume":"11","author":"Kim","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2025.145715_bb0225","article-title":"Advances in humanized mouse models to improve understanding of HIV-1 pathogenesis and immune responses","volume":"11","author":"Gillgrass","year":"2020","journal-title":"Front. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025062701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025062701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:45:15Z","timestamp":1781671515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025062701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":45,"alternative-id":["S0141813025062701"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145715","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel FITC.Chimeric antigen receptor-T cell targeting HIV-1-infected cells with FITC-conjugated antibodies for enhanced cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"145715"}}